113 related articles for article (PubMed ID: 23883205)
1. A radiologist's guide to treatment response criteria in oncologic imaging: anatomic imaging biomarkers.
Rezai P; Pisaneschi MJ; Feng C; Yaghmai V
AJR Am J Roentgenol; 2013 Aug; 201(2):237-45. PubMed ID: 23883205
[TBL] [Abstract][Full Text] [Related]
2. A radiologist's guide to treatment response criteria in oncologic imaging: functional, molecular, and disease-specific imaging biomarkers.
Rezai P; Pisaneschi MJ; Feng C; Yaghmai V
AJR Am J Roentgenol; 2013 Aug; 201(2):246-56. PubMed ID: 23883206
[TBL] [Abstract][Full Text] [Related]
3. [Measurement of tumour response to cancer treatment: morphologic imaging role].
Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
[TBL] [Abstract][Full Text] [Related]
4. Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy.
Yaghmai V; Besa C; Kim E; Gatlin JL; Siddiqui NA; Taouli B
AJR Am J Roentgenol; 2013 Jul; 201(1):80-96. PubMed ID: 23789661
[TBL] [Abstract][Full Text] [Related]
5. Response to treatment series: part 2, tumor response assessment--using new and conventional criteria.
Yaghmai V; Miller FH; Rezai P; Benson AB; Salem R
AJR Am J Roentgenol; 2011 Jul; 197(1):18-27. PubMed ID: 21701006
[TBL] [Abstract][Full Text] [Related]
6. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
Lencioni R; Llovet JM
Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
[TBL] [Abstract][Full Text] [Related]
7. [Activity, objective response, and WHO and RECIST (Response Evaluation Criteria In Solid Tumor) evaluation criteria].
De Angelis V
Suppl Tumori; 2004; 3(4):S7-9. PubMed ID: 15206198
[No Abstract] [Full Text] [Related]
8. Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers.
Vignot S; Besse B; André F; Spano JP; Soria JC
Crit Rev Oncol Hematol; 2012 Dec; 84(3):301-13. PubMed ID: 22710198
[TBL] [Abstract][Full Text] [Related]
9. Response evaluation criteria in solid tumors (RECIST): new guidelines.
Tsuchida Y; Therasse P
Med Pediatr Oncol; 2001 Jul; 37(1):1-3. PubMed ID: 11466715
[No Abstract] [Full Text] [Related]
10. Metastatic disease response to treatment: how many lesions to measure?
Prassopoulos P; Mantatzis M
J Clin Oncol; 2010 Feb; 28(5):e81; author reply 82. PubMed ID: 19841318
[No Abstract] [Full Text] [Related]
11. Assessment of tumor response on MR imaging after locoregional therapy.
Vossen JA; Buijs M; Kamel IR
Tech Vasc Interv Radiol; 2006 Sep; 9(3):125-32. PubMed ID: 17561215
[TBL] [Abstract][Full Text] [Related]
12. Tumor response assessments with diffusion and perfusion MRI.
Li SP; Padhani AR
J Magn Reson Imaging; 2012 Apr; 35(4):745-63. PubMed ID: 22434697
[TBL] [Abstract][Full Text] [Related]
13. Hepatic tumor response evaluation by MRI.
Lee CH; Braga L; de Campos RO; Semelka RC
NMR Biomed; 2011 Jul; 24(6):721-33. PubMed ID: 21793076
[TBL] [Abstract][Full Text] [Related]
14. [Cancer treatment response evaluation based on imaging modalities, such as computed tomography, magnetic resonance imaging and FDG-PET].
Endo M; Aramaki T; Moriguchi M; Sawada A; Asakura K; Bekku E
Gan To Kagaku Ryoho; 2013 Mar; 40(3):294-8. PubMed ID: 23507590
[TBL] [Abstract][Full Text] [Related]
15. Liver metastases in the era of molecular targeted therapy: new faces of treatment response.
Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH
AJR Am J Roentgenol; 2013 Jul; 201(1):W15-28. PubMed ID: 23789688
[TBL] [Abstract][Full Text] [Related]
16. Image-based evaluation of tumor response to treatment: where is radiology today?
Kharuzhyk S; Fabel M; von Tengg-Kobligk H; Kauczor HU
Exp Oncol; 2008 Sep; 30(3):181-9. PubMed ID: 18806739
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the response to treatment in colorectal cancer].
Mikoshiba M; Maeda Y; Sasaki T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():310-4. PubMed ID: 14574901
[No Abstract] [Full Text] [Related]
18. Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
Nishino M; Jagannathan JP; Ramaiya NH; Van den Abbeele AD
AJR Am J Roentgenol; 2010 Aug; 195(2):281-9. PubMed ID: 20651182
[TBL] [Abstract][Full Text] [Related]
19. Clinical biomarkers and imaging for radiotherapy-induced cell death.
Verheij M
Cancer Metastasis Rev; 2008 Sep; 27(3):471-80. PubMed ID: 18470482
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in Alzheimer's disease drug development.
Cummings JL
Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
